drugset / Trial / NCT06644794

Progesterone-modified Natural Cycle for FET

NCT06644794

Phase 3 Recruiting 336 enrolled Shandong University of Traditional Chinese Medicine
RandomizedParallel-groupOpen-labelTreatment

Summary

Hormone replacement therapy (HRT) cycles, despite the ease of synchronizing embryo thawing and embryo transfer timing, increase the risk of pregnancies and obstetric complications compared to natural cycles (NC). By ensuring the presence of the corpus luteum while reducing the number of monitoring sessions, the progesterone modified natural cycle (P4mNC) offers more convenience for the patient than the normal NC. This study is designed to compare the effects of P4mNC and HRT cycles on FET outcomes.

Timeline

Start
2025-03-05
Primary completion
2027-09-10
Completion
2028-12-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Estradiol Other / unclassified 2 mg Oral
Subject Progesterone Other / unclassified 200 mg Intravenous

Indications